See something others should know about? Email CHS or call/txt (206) 399-5959. You can view recent CHS 911 coverage here. Hear sirens and wondering what’s going on? Check out reports ...
Natalizumab (originator and biosimilar) for treating highly active relapsing–remitting multiple sclerosis after disease-modifying therapy TA1126 28 January 2026 28 January 2026 Concizumab for treating ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results